Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative ...

Research and development expenses were $11.4 million for the third quarter ended September 30, 2024, compared to $11.7 million for the comparable period in 2023. The decrease was primarily related to ...

Lausanne, Switzerland, November 13, 2024 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative ... Key Information – Risk ...

Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...

and ROSTOCK, Germany and BERLIN, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (OTC: CNTGF) (“CENTOGENE” or the “Company”), the essential life science partner for data-driven answers in rare and ...

CT1812 slowed cognitive decline by 95% in Alzheimer's disease patients with lower levels of plasma ... Market and the risks and uncertainties described more fully in the "Risk Factors" section of our ...

Enrolled 4 patients in Cohort 2 of the upliFT-D trial for FTD-GRN, with patient dosing advancing as planned; 12-month Cohort 1 and interim Cohort ...

Blueberries and other berries are high in antioxidants, which help guard against free radicals, making them an excellent ...

Clene's cash, cash equivalents and marketable securities totaled $14.6 million as of September 30, 2024, compared to $35.0 million as of December 31, 2023. Clene expects that its resources as of ...

Older adults whose cholesterol levels fluctuate from year to year may face an increased risk for dementia and cognitive ...

An apple a day could keep Alzheimer's at bay, according to research, as the fruit is rich in chemicals that fuel neurons - ...

The Mediterranean diet has gained a research-backed reputation for lowering the risk of chronic diseases ... and inflammation ...